Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 22, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$250,752.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 17, 2026 | Exercise/Conversion | 5,000 | $2.48 | $12,400.00 | 30,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 17, 2026 | Sale | 140 | $45.81 | $6,413.50 | 29,860 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 17, 2026 | Sale | 2,419 | $47.39 | $114,635.44 | 27,441 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 17, 2026 | Sale | 2,441 | $48.06 | $117,303.48 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Apr 17, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 131,268 | Direct | โ | View Details |